Selebran, Aiden D.
HRN: 24-13-87 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/30/2023
MUPIROCIN 2%, 15G (TUBE)
11/30/2023
12/07/2023
TOPICAL
Apply Thinly
Bid
Infected Wound
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes